Tadalafil STELLA 20 mg

Tadalafil is a selective, reversible inhibitor of specific phosphodiesterase type 5 (PDE5). Drug produces an erection in the presence of sexual stimulation.

Pack size Box of 2 tablets.
Shelf-life 36 months.
Composition Tadalafil.
Dosage forms and strengths Film-coated tablet: 20 mg.
Product code :



Tadalafil STELLA 20 mg is used in the management of erectile dysfunction. Tadalafil is effective only in the presence of adequate sexual stimulation.


Usual dose: 10 mg at least 30 minutes before sexual intercourse. The daily dose may be increased to 20 mg or decreased to 5 mg, if necessary. Efficacy may persist for up to 36 hours after dosing. The maximum recommended dosing frequency is once daily and discourage continuous daily use.

Elderly patients: Dosage adjustments are not necessary.

Hepatic impairment mild to moderate: Maximum dose is 10 mg once daily; severe: Not use.

Renal impairment:

  • ClCr = 31 – 50 ml/ minute: Initial with 5 mg, once daily, and maximum dosage is 10 mg no more than once every 48 hours.
  • ClCr < 30 ml/ minute, including those undergoing hemodialysis: Maximum dosage is 5 mg, once daily.

In patients stabilized on alpha blocker therapy, a starting dose 5 mg may be used.

In patients taking potent inhibitors of the CYP3A4, the dose should not exceed 10 mg once every 72 hours.


Tadalafil STELLA 20 mg is administered orally, without regard to meals.

  • Concomitant use of organic nitrates or nitrites, either regularly and/or intermittently.
  • Known hypersensitivity to tadalafil or any ingredient in the formulation.
  • Patients with cardiac disease for whom sexual activity is inadvisable.
  • Patients with visual impairment for monocular due to non-arteritic anterior ischaemic optic neuropathy.
  • Patients with uncontrolled arrhythmias, hypotension (< 90/50 mmHg), or uncontrolled hypertension.
  • Patients with a stroke within the last 6 months.
  • Patients with a myocardial infarction within the last 90 days.
  • Patients with unstable angina or angina occurring during sexual intercourse.
  • Patients with class 2 or greater heart failure in the last 6 months.

Common: Headache, flushing, nasal congestion, dyspepsia, gastro-oesophageal reflux, back pain, myalgia, pain in extremity.

  • It is necessary to assess the cardiovascular status of the patient prior to initiating tadalafil therapy. Serious cardiovascular events, including myocardial infarction, sudden cardiac death, stroke, chest pain, palpitations, and tachycardia, have been reported.
  • Use of tadalafil currently is not recommended in patients with hereditary degenerative retinal disorders, including retinitis pigmentosa.
  • Use with caution in patients with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, Peyronie’s disease) and with conditions that may predispose to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia).
  • Combined use of tadalafil and other therapies for erectile dysfunction currently is not recommended.
  • Tadalafil STELLA 20 mg contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
  • The drug is not indicated for use in children, neonates and women.
  • Patients should be aware of how they react to tadalafil before driving or operating machinery.